Here’s a longer, more detailed and engaging version of the text in English, expanded with extra context, explanations, quotes, and implications while keeping the core content exactly the same:In a major scientific breakthrough announced in late 2025, researchers have developed an innovative method to upcycle old plastic bottles and other everyday household waste into a high-value chemical ingredient essential for producing life-saving anti-cancer medications. Rather than merely recycling PET (polyethylene terephthalate)—the common plastic used in water bottles, soda bottles, food containers, and synthetic clothing—into more low-grade plastics or basic materials, this new approach transforms the waste into something far more valuable: a key pharmaceutical building block.The team, led by scientists at the University of St Andrews in Scotland, published their findings in the prestigious journal Angewandte Chemie International Edition. They employed a sophisticated ruthenium-catalyzed semi-hydrogenation process to chemically depolymerise PET waste, breaking down its long polymer chains into a specific compound known as ethyl-4-hydroxymethyl benzoate (EHMB). This intermediate molecule is incredibly useful—it serves as a crucial precursor in the synthesis of several important drugs and chemicals.
Most notably, EHMB can be used to produce Imatinib, the blockbuster anti-cancer medication (commonly known as Gleevec) that has revolutionized treatment for chronic myeloid leukemia and other cancers by targeting specific proteins in cancer cells. Beyond oncology, the compound also helps synthesize Tranexamic acid, a vital drug that prevents excessive bleeding and promotes blood clotting during surgeries or heavy menstrual bleeding, as well as Fenpyroximate, an effective insecticide used in agriculture.What makes this discovery particularly exciting is its potential to shift pharmaceutical manufacturing away from traditional fossil-fuel-derived feedstocks, which often involve hazardous chemicals and generate massive amounts of waste (sometimes up to 100 kg of chemical waste per kg of active drug ingredient). By sourcing these high-value intermediates from abundant plastic trash instead, the process could dramatically reduce environmental pollution, cut reliance on petroleum-based resources, and create a more sustainable supply chain for essential medicines.Lead author Dr. Amit Kumar from the School of Chemistry at St Andrews expressed enthusiasm about the implications: “We are excited by this discovery, which reimagines PET waste as a promising new feedstock for generating high-value APIs (Active Pharmaceutical Ingredients) and agrochemicals. By enabling the upcycling of plastic waste into premium products instead of reproducing the same class of plastics, such processes could meaningfully accelerate the transition to a circular economy.”
The researchers didn’t stop at pharmaceuticals—they also demonstrated that EHMB can be further converted into entirely new, fully recyclable polyesters. This opens the door to broader applications in creating sustainable, closed-loop material systems where plastic waste fuels both medical advancements and eco-friendly materials.While the technology is still in the early research stages and not yet scaled for industrial production, it represents a promising step toward a future where common plastic pollution doesn’t just end up in landfills or oceans but actively contributes to solving global health challenges. Instead of being an environmental burden, discarded bottles could one day help supply the very compounds needed to fight cancer and save lives—turning trash into treasure in the most literal and impactful way possible.Research Paper
